Role of plasma vitamin D and iron in the prognosis of mortality in patients with sepsis

  • Nguyen Van Tuan 108 Military Central Hospital
  • Quach Xuan Hinh 108 Military Central Hospital
  • Le Huu Song 108 Military Central Hospital

Main Article Content

Keywords

Sepsis, vitamin D, iron

Abstract

Objective: To determine 30-day mortality prognostic value of plasma vitamin D and iron levels in patients with sepsis. Subject and method: A prospective descriptive study was conducted on 125 patients with sepsis treated at 108 Military Central Hospital from November 2019 to February 2021. Plasma vitamin D and iron levels were measured at the time of definitive diagnosis with sepsis, 30-day follow-up of survival and mortality. Result: The plasma vitamin D and iron levels at the time of definitive diagnosis with sepsis were 20.41 (15.03-30.25) ng/mL and 1.9 (1.0-4.0) µmol/L, respectively. The levels of plasma vitamin D in the 30-day mortality group were lower than the survival group (p=0.004). Patients with plasma vitamin D levels < 15.74ng/mL had a higher risk of 30-day mortality than patients with plasma vitamin D levels ≥ 15.74ng/mL, OR 4.26 (1.84-9.90), p<0.001. The plasma iron levels in the 30-day mortality group were higher in the survival group (p=0.016). Patients with plasma iron levels ≥ 1.75µmol/L had a higher risk of 30-day mortality than patients with iron levels < 1.75µmol/L, OR = 3.63 (1.49-8.86), p=0.003. Conclusion: Plasma vitamin D levels < 15.74ng/mL and plasma iron levels ≥ 1.75µmol/L may be risk factors for 30-day mortality in patients with sepsis.

Article Details

References

1. Fleischmann C, Scherag A, Adhikari NK et al (2016) Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 193(3): 259-272.
2. Rossetti M, Martucci G, Starchl C et al (2021) Micronutrients in Sepsis and COVID-19: A Narrative Review on What We Have Learned and What We Want to Know in Future Trials. Medicina (Kaunas) 57(5): 419.
3. Ganz T, Nemeth E (2015) Iron homeostasis in host defence and inflammation. Nat Rev Immunol 15(8): 500-510.
4. Ayoglu H, Sezer U, Akin M et al (2016) Selenium, copper, zinc, iron levels and mortality in patients with sepsis and systemic inflammatory response syndrome in Western Black Sea Region, Turkey. J Pak Med Assoc 66(4): 447-452.
5. Lan P, Pan KH, Wang SJ et al (2018) High Serum Iron level is Associated with Increased Mortality in Patients with Sepsis. Scientific reports 8(1): 11072-11072.
6. Jiang Y, Jiang FQ, Kong F et al (2019) Inflammatory anemia-associated parameters are related to 28-day mortality in patients with sepsis admitted to the ICU: A preliminary observational study. Ann Intensive Care 9(1): 67.
7. Singer M, Deutschman CS, Seymour C et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). Jama 315(8): 801-810.
8. Brandtner A, Tymoszuk P, Nairz M et al (2020) Linkage of alterations in systemic iron homeostasis to patients' outcome in sepsis: A prospective study. J Intensive Care 8: 76.
9. Bayat M, Gachkar L, Zahirnia M et al (2021) Association between low serum vitamin d levels and sepsis: A single-center study in Tehran, Iran. 16(1): 102926.
10. Shojaei M, Sabzeghabaei A, Valaei Barhagh H et al (2019) The Correlation between Serum Level of Vitamin D and Outcome of Sepsis Patients; A Cross-Sectional Study. Arch Acad Emerg Med 7(1): 1.
11. Rech MA, Hunsaker T, Rodriguez J (2014) Deficiency in 25-hydroxyvitamin D and 30-day mortality in patients with severe sepsis and septic shock. Am J Crit Care 23(5): 72-79.
12. Li Y, Ding S (2020) Serum 25-Hydroxyvitamin D and the risk of mortality in adult patients with Sepsis: a meta-analysis. BMC Infect Dis 20(1): 189.
13. Trongtrakul K, Feemuchang C (2017) Prevalence and association of vitamin D deficiency and mortality in patients with severe sepsis. Int J Gen Med 10: 415-421.
14. Chen Z, Luo Z, Zhao X et al (2015) Association of vitamin D status of septic patients in intensive care units with altered procalcitonin levels and mortality. J Clin Endocrinol Metab 100(2): 516-523.